Central African Republic vs France: The number of people with susceptibility test result for rifampicin

Central African Republic
9.75
in 2021
France
1.45
in 2021
Central African Republic rank
139th
France rank
141st

The number of people with susceptibility test result for rifampicin over time

  • Central African Republic
  • France
050100150200201720192021

How they compare

Central African Republic currently reports 9.75 against 1.45 in France, a difference of 8.3.

That makes Central African Republic's figure about 6.7 times France's.

The two have swapped places 1 time across 5 shared years of data; in 2017 it was France ahead.

Central African Republic ranks 139th and France ranks 141st of 146 countries.

Across the 2 decades both report, Central African Republic averaged higher in 1 and France in 1.

Head to head by decade

Decade Central African Republic France Difference Ahead
2010s 1.64 137.55 135.91 France
2020s 10.12 1.66 8.45 Central African Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Central African Republic or France?
Central African Republic, at 9.75 against 1.45 in France as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Central African Republic and France?
8.3, with Central African Republic ahead.
How many years of comparable data are there for Central African Republic and France?
5 years are reported by both, from 2017 to 2021.
How do Central African Republic and France rank globally for the number of people with susceptibility test result for rifampicin?
Central African Republic ranks 139th and France ranks 141st of 146 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs France: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/central-african-republic/france/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/central-african-republic/france/">Central African Republic vs France: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed